• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
  • Blog
  • Free Resources
RevistaLab

RevistaLab

  • About
    • Meet Revista
    • Partners
    • Press
    • Sponsorship
    • Contact Us
  • Events
  • Why Subscribe?
    • Subscriptions
    • Business Development
    • Underwriting & Due Diligence
    • Development
    • Asset Management
    • Leasing
  • SUBSCRIBER LOGIN
Home / Construction/Development / What Percentage of the Life Science Construction Pipeline is Pre-leased?

What Percentage of the Life Science Construction Pipeline is Pre-leased?

November 15, 2024 by Stephen Lindsey Topics: Construction/Development, Leasing/Property Management

To answer this question, we are going to break up the data into two categories, the top 3 markets (Boston, San Francisco, San Diego) and the rest of the US. We are showing the square footage of construction projects that are in progress, the amount of that construction that is still available to be leased (SF Vacant in Progress) and the vacancy percentage based on those numbers. The top 3 markets had a construction vacancy of 31% in 3Q24. This is down from the peak of 40% we saw in 2023. The overall trend shows a clear increase in speculative development in 2022, a leveling out in 2023, and a downward trend starting in 2024. The pattern is not the same for the markets in the rest of the U.S. Outside the top 3, construction vacancies only rose steadily in 2022, and didn’t go over 10% until 2023. Now the trend is stabilizing at around 17%. Part of the gap between the two sets can be explained by the presence of user-owned buildings. This data contains both investor-owned projects, as well as user-owned developments from pharmaceutical and life science companies. The user-owned projects will typically be fully occupied, and since they take up a larger portion in secondary markets, they tend to push the vacancy levels lower.  

Stephen Lindsey
Stephen Lindsey

Other Articles by Stephen Lindsey:

    • Manufacturing: A Healthier Subsection of Life Science Real Estate
    • First Look at 1Q25 Life Science Transaction Activity
    • Absorption Across the Top 20 Life Science Markets

Previous Post:Life Science Occupancy Flattens in 3Q
Next Post:4Q Life Science Inventory Reaches 400 Million Square Feet

Sidebar

Topics

  • Construction/Development
  • Industry News
  • Leasing/Property Management
  • Mergers/Acquisitions
  • Policy/Legislation
  • Real Estate Financing/Capital Markets
  • Revista News
  • Uncategorized

Recent Posts

  • Manufacturing: A Healthier Subsection of Life Science Real Estate
  • New Deliveries, Older Properties Most Impacted by Oversupply
  • First Look at 1Q25 Life Science Transaction Activity
  • Life Science Deliveries Stall in 1Q, Pipeline Still Significant
  • Absorption Across the Top 20 Life Science Markets

Archives

Other Free Resources

Life Science Real Estate Industry Professionals

Search for and/or list your life science real estate services in Revista’s life science real estate directory.

Reports & White Papers

Download free reports & white papers on life science real estate.

Archives

  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • February 2024
  • November 2023
  • October 2023
  • August 2023
  • July 2023
  • June 2023
  • March 2023
  • October 2022
  • September 2022

Categories

  • Construction/Development
  • Industry News
  • Leasing/Property Management
  • Mergers/Acquisitions
  • Policy/Legislation
  • Real Estate Financing/Capital Markets
  • Revista News
  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Ready to Schedule a Demo?

Get in Touch Now
  • Why Subscribe?
  • Events
  • The LAB Report
  • Add A Life Science Directory Listing
  • Contact Us
  • Sponsorship
  • About
  • Terms of Use
  • Press

SIGN UP FOR LAB REPORT NEWSLETTER

  • Twitter
  • Facebook
  • LinkedIn